Skip to content

Evaluation of the effectiveness of hypnotherapy on polycystic ovary syndrome

The comparison of hypnotherapy and routine care on the resilience of women with polycystic ovary syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20161126031117N12
Enrollment
56
Registered
2022-05-04
Start date
2022-03-25
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: In the intervention group, hypnotherapy is performed by a trained researcher who is trained in the Iranian Association of Clinical Hypnosis and has a valid certific

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: single or married women with confirmed polycystic ovarian syndrome according to Rotterdam criteria Have come to visit for the first time because of this disease being able to read and write or speak in Persian have Iranian nationality being satisfied to participate in the research

Exclusion criteria

Exclusion criteria: Occurrence of any kind of acute complication affecting the quality of life and resilience during the intervention, such as the death of important people in a person's life. being suffering from other endocrine diseases or any other chronic diseases which affect patient`s quality of life such as Chronic debilitating liver and kidney disease being psychotic and having serious thoughts of harm to oneself and others (recognized by a psychiatrist) being Infertile and undergoing assisted reproductive therapy history of seizures using psychotropic drugs and any kind of drug abuse participating in similar training sessions

Design outcomes

Primary

MeasureTime frame
Resilience. Timepoint: before intervention, 6 weeks after starting the intervention, 4 weeks after ending the intervention. Method of measurement: Connor-Davidson Resilience Scale.

Secondary

MeasureTime frame
Quality of life. Timepoint: before intervention, 6 weeks after starting the intervention, 4 weeks after ending the intervention. Method of measurement: PCOS Health-Related Quality of Life Questionnaire.;Anxiety and depression. Timepoint: before intervention, 6 weeks after starting the intervention, 4 weeks after ending the intervention. Method of measurement: Hospital Anxiety and Depression Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahtab Hajimohammadreza

Mazandaran University of Medical Sciences

mw.mahtabhmr@gmail.com+98 21 5593 6961

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026